Live
Cipla has got the Competition Commission of India’s approval for the proposed investment by FIL Capital Investment in its consumer healthcare business vertical.
Cipla has informed in the regulatory filing that the Competition Commission of India has granted approval to the proposed investment by FIL Capital Investments (Mauritius) II Limited in Cipla Health Limited, subsidiary of the company.
The company has further said that “the investment is still subject to, amongst other conditions precedent, approval from the Foreign Investment Promotion Board and the transfer of company’s consumer healthcare business to Cipla Health Ltd”.
